Victory Capital Management Inc Pacira Bio Sciences, Inc. Transaction History

Victory Capital Management Inc

$95.7 Billion
Q4 2024

A detailed history of Victory Capital Management Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 94,750 shares of PCRX stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,750

Previous 122,228 22.48%

Holding current value

$2.29 Million

Previous $1.84 Million 2.99%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$15.3 - $20.33 $420,413 - $558,627	-27,478 Reduced 22.48%	94,750 $1.79 Million
Q3 2024 Nov 05, 2024	BUY	$11.7 - $28.46 $404,691 - $984,402	34,589 Added 39.47%	122,228 $1.84 Million
Q2 2024 Aug 05, 2024	BUY	$25.5 - $31.51 $351,288 - $434,081	13,776 Added 18.65%	87,639 $2.51 Million
Q1 2024 May 03, 2024	BUY	$27.7 - $35.48 $229,882 - $294,448	8,299 Added 12.66%	73,863 $2.16 Million
Q4 2023 Feb 05, 2024	SELL	$26.32 - $34.31 $82,197 - $107,150	-3,123 Reduced 4.55%	65,564 $2.21 Million
Q3 2023 Nov 06, 2023	SELL	$30.68 - $40.09 $44,363 - $57,970	-1,446 Reduced 2.06%	68,687 $2.11 Million
Q2 2023 Jul 27, 2023	BUY	$36.12 - $47.5 $85,496 - $112,432	2,367 Added 3.49%	70,133 $2.81 Million
Q1 2023 May 02, 2023	BUY	$35.53 - $43.38 $113,305 - $138,338	3,189 Added 4.94%	67,766 $2.77 Million
Q4 2022 Feb 10, 2023	BUY	$38.19 - $57.45 $109,376 - $164,536	2,864 Added 4.64%	64,577 $2.49 Million
Q4 2022 Feb 09, 2023	SELL	$38.19 - $57.45 $470,118 - $707,209	-12,310 Reduced 16.63%	61,713 $2.38 Million
Q3 2022 Nov 02, 2022	BUY	$51.24 - $58.89 $450,143 - $517,348	8,785 Added 13.47%	74,023 $3.94 Million
Q2 2022 Aug 01, 2022	SELL	$51.49 - $81.64 $313,007 - $496,289	-6,079 Reduced 8.52%	65,238 $3.8 Million
Q1 2022 May 04, 2022	SELL	$60.03 - $76.49 $201,460 - $256,700	-3,356 Reduced 4.49%	71,317 $5.4 Million
Q4 2021 Feb 07, 2022	BUY	$47.97 - $62.21 $139,065 - $180,346	2,899 Added 4.04%	74,673 $4.49 Million
Q3 2021 Nov 02, 2021	BUY	$54.64 - $61.3 $158,893 - $178,260	2,908 Added 4.22%	71,774 $4.02 Million
Q2 2021 Aug 03, 2021	SELL	$59.18 - $69.99 $899,121 - $1.06 Million	-15,193 Reduced 18.07%	68,866 $4.18 Million
Q1 2021 May 04, 2021	BUY	$59.31 - $78.82 $3.98 Million - $5.29 Million	67,140 Added 396.83%	84,059 $5.89 Million
Q4 2020 Feb 01, 2021	SELL	$50.47 - $66.26 $45,069 - $59,170	-893 Reduced 5.01%	16,919 $1.01 Million
Q3 2020 Nov 09, 2020	BUY	$51.97 - $63.0 $264,475 - $320,607	5,089 Added 40.0%	17,812 $1.07 Million
Q2 2020 Aug 07, 2020	BUY	$30.8 - $52.47 $25,071 - $42,710	814 Added 6.84%	12,723 $668,000
Q1 2020 May 04, 2020	BUY	$28.4 - $50.7 $2,556 - $4,563	90 Added 0.76%	11,909 $399,000
Q4 2019 Feb 06, 2020	BUY	$36.31 - $46.83 $31,807 - $41,023	876 Added 8.01%	11,819 $535,000
Q4 2019 Feb 04, 2020	BUY	$36.31 - $46.83 $76,178 - $98,249	2,098 Added 23.72%	10,943 $473,000
Q3 2019 Nov 12, 2019	BUY	$35.66 - $44.99 $315,412 - $397,936	8,845 New	8,845 $337,000

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

49.8M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.11B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Pacira Bio Sciences, Inc. Transaction History